Log in
OTCMKTS:BPMUF

Basilea Pharmaceutica Stock Forecast, Price & News

$55.52
0.00 (0.00 %)
(As of 09/22/2020 12:00 AM ET)
Add
Compare
Today's Range
$55.52
Now: $55.52
$55.52
50-Day Range
$55.47
MA: $55.56
$55.77
52-Week Range
$36.95
Now: $55.52
$60.05
VolumeN/A
Average Volume100 shs
Market Capitalization$596.28 million
P/E RatioN/A
Dividend YieldN/A
Beta1.59
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers isavuconazole, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, the European Union, and internationally under the Cresemba brand. The company also provides ceftobiprole, an intravenous antibiotic for the treatment of adult patients with community and hospital-acquired pneumonia, excluding ventilator-associated pneumonia under the Zevtera name in European and various non-European countries. In addition, it engages in developing Derazantinib, an orally administered small molecule inhibitor, which is in a clinical study for the treatment intrahepatic cholangiocarcinoma, a form of biliary tract cancer; BAL101553, a tumor checkpoint controller drug for tumor types unresponsive to standard therapeutics; and BAL3833, an orally available small-molecule drug candidate for use as a panRAF/SRC kinase inhibitor targeting cell signaling pathways. The company was founded in 2000 and is headquartered in Basel, Switzerland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.57 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BPMUF
CUSIPN/A
CIKN/A
Phone41-61-606-1111

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$135.28 million
Book Value($7.88) per share

Profitability

Miscellaneous

Employees227
Market Cap$596.28 million
Next Earnings DateN/A
OptionableNot Optionable
$55.52
0.00 (0.00 %)
(As of 09/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BPMUF News and Ratings via Email

Sign-up to receive the latest news and ratings for BPMUF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Basilea Pharmaceutica (OTCMKTS:BPMUF) Frequently Asked Questions

How has Basilea Pharmaceutica's stock price been impacted by COVID-19?

Basilea Pharmaceutica's stock was trading at $44.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BPMUF shares have increased by 25.3% and is now trading at $55.52.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Basilea Pharmaceutica?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Basilea Pharmaceutica in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Basilea Pharmaceutica
.

Who are some of Basilea Pharmaceutica's key competitors?

Who are Basilea Pharmaceutica's key executives?

Basilea Pharmaceutica's management team includes the following people:
  • Mr. David Veitch, Chief Exec. Officer (Age 54)
  • Mr. Adesh Kaul, Chief Financial Officer (Age 45)
  • Dr. Laurenz Kellenberger, Chief Scientific Officer (Age 52)
  • Dr. Marc Engelhardt, Chief Medical Officer (Age 55)
  • Dr. Gerrit Hauck, Chief Technology Officer (Age 55)

What is Basilea Pharmaceutica's stock symbol?

Basilea Pharmaceutica trades on the OTCMKTS under the ticker symbol "BPMUF."

How do I buy shares of Basilea Pharmaceutica?

Shares of BPMUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Basilea Pharmaceutica's stock price today?

One share of BPMUF stock can currently be purchased for approximately $55.52.

How big of a company is Basilea Pharmaceutica?

Basilea Pharmaceutica has a market capitalization of $596.28 million and generates $135.28 million in revenue each year. The company earns $-22,490,000.00 in net income (profit) each year or ($2.09) on an earnings per share basis. Basilea Pharmaceutica employs 227 workers across the globe.

What is Basilea Pharmaceutica's official website?

The official website for Basilea Pharmaceutica is www.basilea.com.

How can I contact Basilea Pharmaceutica?

Basilea Pharmaceutica's mailing address is Grenzacherstrasse 487, Basel V8, 4058. The company can be reached via phone at 41-61-606-1111 or via email at [email protected]

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.